The biology of Kaposi's sarcoma.

[1]  M. Corbellino,et al.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.

[2]  Jae U. Jung,et al.  Identification of the Novel K15 Gene at the Rightmost End of the Kaposi's Sarcoma-Associated Herpesvirus Genome , 2000, Journal of Virology.

[3]  L. Chieco‐Bianchi,et al.  Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. , 1999, European journal of cancer.

[4]  D. Burstein,et al.  Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. , 1999, The American journal of surgical pathology.

[5]  C. Rabkin,et al.  Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. , 1999, The Journal of infectious diseases.

[6]  P. Biberfeld,et al.  The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors , 1999, The Journal of experimental medicine.

[7]  T. Mack,et al.  The risk of angiosarcoma following primary breast cancer , 1999, British Journal of Cancer.

[8]  S. Halevy,et al.  Stewart-Treves syndrome in a patient with elephantiasis. , 1999, Journal of the American Academy of Dermatology.

[9]  L. Rainbow,et al.  Identification of a Spliced Gene from Kaposi’s Sarcoma-Associated Herpesvirus Encoding a Protein with Similarities to Latent Membrane Proteins 1 and 2A of Epstein-Barr Virus , 1999, Journal of Virology.

[10]  M. Reitz,et al.  Comparison of Genetic Variability at Multiple Loci across the Genomes of the Major Subtypes of Kaposi’s Sarcoma-Associated Herpesvirus Reveals Evidence for Recombination and for Two Distinct Types of Open Reading Frame K15 Alleles at the Right-Hand End , 1999, Journal of Virology.

[11]  Moore,et al.  Response from schulz and moore , 1999, Trends in microbiology.

[12]  Lijun Wu,et al.  A Complex Translational Program Generates Multiple Novel Proteins from the Latently Expressed Kaposin (K12) Locus of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.

[13]  J. Kaleeba,et al.  A Rhesus Macaque Rhadinovirus Related to Kaposi’s Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Encodes a Functional Homologue of Interleukin-6 , 1999, Journal of Virology.

[14]  V. Sondak,et al.  Recent Advances in Melanoma Staging and Therapy , 1999, Annals of Surgical Oncology.

[15]  B. Herndier.  Cancer (or lack thereof) and viruses. , 1999, Trends in microbiology.

[16]  V. Beral,et al.  Antibodies against human herpesvirus 8 in black South African patients with cancer. , 1999, The New England journal of medicine.

[17]  E. Jaffe,et al.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.

[18]  P. Monini,et al.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. , 1999, Blood.

[19]  G. Hayward,et al.  KSHV strains: the origins and global spread of the virus. , 1999, Seminars in cancer biology.

[20]  R. Majeti,et al.  Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Sun,et al.  Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease , 1999, Journal of Virology.

[22]  T. Schulz,et al.  Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how? , 1999, Trends in microbiology.

[23]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[24]  E. van Marck,et al.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. de Thé,et al.  Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa , 1999, International journal of cancer.

[26]  A. Palestine,et al.  Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.

[27]  R. Searles,et al.  Sequence and Genomic Analysis of a Rhesus Macaque Rhadinovirus with Similarity to Kaposi’s Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 , 1999, Journal of Virology.

[28]  E. Castaños-Vélez,et al.  Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions , 1999, Medical oncology.

[29]  D. Kufe,et al.  Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences. , 1999, Blood.

[30]  H. Goldschmidt,et al.  Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  P. Moore,et al.  Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter , 1999, Journal of Virology.

[32]  T. Hercend,et al.  A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation , 1999, European journal of immunology.

[33]  N. Jones,et al.  Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus , 1999 .

[34]  I. Binet,et al.  Transplantation-associated Kaposi's sarcoma: herpesvirus 8 transmission through renal allografts. , 1999, Transplantation proceedings.

[35]  P. Coulie,et al.  Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 , 1999, International journal of cancer.

[36]  J. Orenstein,et al.  Appearance of human herpesvirus 8 on electron microscopy. , 1999, The New England journal of medicine.

[37]  R. Gallo.  The Enigmas of Kaposi's Sarcoma , 1998, Science.

[38]  A. Ribas,et al.  Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. , 1998, Journal of immunology.

[39]  A. Blauvelt,et al.  No evidence of human herpesvirus 8 infection in patients with paraneoplastic pemphigus, pemphigus vulgaris, or pemphigus foliaceus. , 1998, The Journal of investigative dermatology.

[40]  A. Haase,et al.  A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.

[41]  K. Tarte,et al.  Evidence against KSHV infection in the pathogenesis of multiple myeloma. , 1998, Virus research.

[42]  L. Cuevas,et al.  Prevalence and transmission of Kaposi's sarcoma‐associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents , 1998, International journal of cancer.

[43]  C. Cockerell,et al.  Update on cutaneous manifestations of HIV infection. , 1998, The Medical clinics of North America.

[44]  Jae U. Jung,et al.  Identification of an Immunoreceptor Tyrosine-Based Activation Motif of K1 Transforming Protein of Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Molecular and Cellular Biology.

[45]  S. Rafii,et al.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus , 1998, Nature.

[46]  M. Corbellino,et al.  Posttransplant human herpes virus 8 infection and seroconversion in a Kaposi's sarcoma affected kidney recipient transplanted from a human herpes virus 8 positive living related donor. , 1998, Transplantation proceedings.

[47]  P. Georgii‐Hemming,et al.  Blood Dendritic Cells From Myeloma Patients Are Not Infected With Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) , 1998 .

[48]  B. Nathwani,et al.  Evidence for multiclonality in multicentric Kaposi's sarcoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Schulz,et al.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 1998, The Journal of general virology.

[50]  K. Ozato,et al.  Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor , 1998, Journal of Virology.

[51]  Jeffrey N. Martin,et al.  Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.

[52]  D. Knowles.  Immunodeficiency-associated lymphoproliferative disorders. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[53]  R. Gallo.  Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. , 1998, Journal of the National Cancer Institute. Monographs.

[54]  R. Desrosiers,et al.  Deregulation of cell growth by the K1 gene of Karposi's sarcoma-associated herpesvirus , 1998, Nature Medicine.

[55]  B. Chandran,et al.  Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. , 1998, Virology.

[56]  E. Cesarman,et al.  Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[57]  C. Boshoff,et al.  Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. , 1998, Journal of the National Cancer Institute.

[58]  T. Schulz,et al.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. , 1998, Journal of human virology.

[59]  B. Ensoli,et al.  Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. , 1998, Cytokine & growth factor reviews.

[60]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[61]  S. Goodbourn,et al.  Human Herpesvirus 8 Encodes an Interferon Regulatory Factor (IRF) Homolog That Represses IRF-1-Mediated Transcription , 1998, Journal of Virology.

[62]  C. Boshoff.  Kaposi's sarcoma: Coupling herpesvirus to angiogenesis , 1998, Nature.

[63]  G. Pinkus,et al.  Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. , 1997, Blood.

[64]  R. Desrosiers,et al.  A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus , 1997, Journal of virology.

[65]  M. Corbellino,et al.  Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. , 1997, The American journal of pathology.

[66]  D. Ganem,et al.  Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. , 1997, The Journal of clinical investigation.

[67]  N. Jones,et al.  Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins , 1997, Nature.

[68]  M. Strnad,et al.  Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine. , 1997, Anti-cancer drugs.

[69]  C. Boshoff,et al.  KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway , 1997, Oncogene.

[70]  C. Boshoff,et al.  Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. , 1997, Science.

[71]  B. Haar,et al.  Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.

[72]  M. Moroni,et al.  Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. , 1997, Blood.

[73]  I. Penn.  Kaposi's sarcoma in transplant recipients. , 1997, Transplantation.

[74]  D. Ganem,et al.  The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. , 1997, Virology.

[75]  K. Jeang,et al.  Human herpesvirus 8 infection occurs following adolescence in the United States. , 1997, The Journal of infectious diseases.

[76]  L. Corey,et al.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma , 1997, Journal of virology.

[77]  M. Goldsmith,et al.  A Kaposi’s Sarcoma-associated Herpesvirus-encoded Cytokine Homolog (vIL-6) Activates Signaling through the Shared gp130 Receptor Subunit* , 1997, The Journal of Biological Chemistry.

[78]  É. Oksenhendler,et al.  Molecular analysis of clonality in Kaposi's sarcoma. , 1997, Journal of clinical pathology.

[79]  L. Rainbow,et al.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.

[80]  B. Chandran,et al.  Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. , 1997, The Journal of infectious diseases.

[81]  J. Said,et al.  Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. , 1997, Science.

[82]  C. Boshoff,et al.  The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 , 1997, Journal of virology.

[83]  F. Neipel,et al.  Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.

[84]  J. Goedert,et al.  Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA , 1997, The Lancet.

[85]  S. Menzies,et al.  Complete regression of primary cutaneous malignant melanoma. , 1997, Archives of surgery.

[86]  L. Liotta,et al.  Monoclonal origin of multicentric Kaposi's sarcoma lesions. , 1997, The New England journal of medicine.

[87]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[88]  K. Jeang,et al.  Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy , 1997, AIDS.

[89]  M. Reitz,et al.  Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate , 1997, Journal of virology.

[90]  J. Russo,et al.  Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue , 1997, Nature Medicine.

[91]  F. Neipel,et al.  Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin , 1997, Journal of virology.

[92]  H. Koeffler,et al.  Is Kaposi's Sarcoma–Associated Herpesvirus Ubiquitous in Urogenital and Prostate Tissues? , 1997 .

[93]  R. Greenblatt,et al.  The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. , 1997, JAMA.

[94]  C. Tacchetti,et al.  HIV is trapped and masked in the cytoplasm of lymph node follicular dendritic cells. , 1997, The American journal of pathology.

[95]  E. Cesarman,et al.  Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.

[96]  A. Haase,et al.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.

[97]  F. Neipel,et al.  Human herpesvirus 8 encodes a homolog of interleukin-6 , 1997, Journal of virology.

[98]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[99]  C. Boshoff,et al.  Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.

[100]  W. Zhong,et al.  The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.

[101]  M. McGrath,et al.  The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[102]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[103]  H. Koeffler,et al.  Absence of HHV-8 in prostate and semen. , 1996, The New England journal of medicine.

[104]  M. Corbellino,et al.  Absence of HHV-8 in prostate and semen. , 1996, The New England journal of medicine.

[105]  M. Offermann.  HHV-8: a new herpesvirus associated with Kaposi's sarcoma. , 1996, Trends in microbiology.

[106]  C. Boshoff,et al.  Cyclin encoded by KS herpesvirus , 1996, Nature.

[107]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[108]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[109]  W. Zhong,et al.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[110]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[111]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.

[112]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[113]  J. Varon,et al.  Moritz Kaposi: idiopathic pigmented sarcoma of the skin. , 1995, The Journal of emergency medicine.

[114]  Yi Fang Liu,et al.  Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms , 1995, Cancer.

[115]  A. Albini,et al.  Angiogenic properties of human immunodeficiency virus type 1 Tat protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[116]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[117]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[118]  J. Ambroziak,et al.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.

[119]  M. McGrath,et al.  Identification of a clonal form of HIV in early Kaposi's sarcoma: evidence for a novel model of oncogenesis, "sequential neoplasia". , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[120]  P. Volberding,et al.  Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. , 1995, Blood.

[121]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[122]  W. Grafton.  Regressing malignant melanoma. , 1994, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[123]  M. Akira,et al.  Pulmonary hyalinizing granuloma with Castleman's disease. , 1994, Internal medicine.

[124]  M. Amoss,et al.  Histopathology of regression in sinclair swine model of melanoma. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[125]  I. Avinoach,et al.  Metastatic Malignant Melanoma with Spontaneous and Complete Regression of the Primary Lesion , 1994 .

[126]  R. Gallo,et al.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[127]  L. Weiss,et al.  Assessment of clonality in lymphoid proliferations. , 1993, The American journal of pathology.

[128]  O. Hennessy,et al.  Case report: fatal pulmonary Kaposi's sarcoma and Castleman's disease in a renal transplant recipient. , 1993, The British journal of radiology.

[129]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[130]  L. Buonaguro,et al.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines , 1992, Journal of virology.

[131]  R. Gallo,et al.  Cytokines and Growth Factors in the Pathogenesis of AIDS‐Associated Kaposi's Sarcoma , 1992, Immunological reviews.

[132]  M. McGrath,et al.  Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[133]  M. Rosenblum,et al.  Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. , 1991, AIDS.

[134]  R. Gallo,et al.  Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1991, Hematology/oncology clinics of North America.

[135]  B. Aggarwal,et al.  HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. , 1990, The Journal of biological chemistry.

[136]  M. Gaffey,et al.  Viral oncogenesis: Epstein-Barr virus. , 1990, American journal of otolaryngology.

[137]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[138]  V. Beral,et al.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.

[139]  S. Salahuddin,et al.  AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis. , 1989, Cancer cells.

[140]  R. Simmons,et al.  Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. , 1989, Transplantation.

[141]  S. Nakamura,et al.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.

[142]  R. Dorfman.  Kaposi's sarcoma: evidence supporting its origin from the lymphatic system. , 1988, Lymphology.

[143]  M. Raffeld,et al.  Molecular genetics and the diagnosis of lymphoma. , 1988, Archives of pathology & laboratory medicine.

[144]  C. Orfanos,et al.  Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. , 1987, The American Journal of dermatopathology.

[145]  E. Jaffe,et al.  Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. , 1987, The Journal of clinical investigation.

[146]  F. Enzinger,et al.  Soft tissue tumors , 1988 .

[147]  R. Dorfman.  The histogenesis of Kaposi's sarcoma. , 1984, Lymphology.

[148]  A. Ackerman,et al.  Kaposi's sarcoma: an extensively disseminated form in young homosexual men. , 1982, Human pathology.

[149]  S. Zolla-Pazner,et al.  Disseminated Kaposi's sarcoma in homosexual men. , 1982, Annals of internal medicine.

[150]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[151]  J. Rosai,et al.  Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. , 1981, Cancer research.

[152]  J. Najarian,et al.  Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. , 1981, Cancer research.

[153]  F. Stewart,et al.  Lymphangiosarcoma in postmastectomy lymphedema: A report of six cases in elephantiasis chirurgica , 1981 .

[154]  E. Beth,et al.  Etiological implications on Kaposi's sarcoma. , 1981, Antibiotics and chemotherapy.

[155]  H. Kamino,et al.  A histologic atlas of vascular lesions. , 1978, The Journal of dermatologic surgery and oncology.

[156]  S. S. St. Jeor,et al.  Partial characterization of a herpes-type virus (K9V) derived from Kaposi's sarcoma. , 1977, Journal of the National Cancer Institute.

[157]  M. Hapke,et al.  Capsule dermatopathology. Kaposi's sarcoma vs. pyogenic granuloma. , 1976, The Journal of dermatologic surgery.

[158]  B. Safai,et al.  Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of american Kaposi's sarcoma with cytomegalovirus , 1975, International journal of cancer.

[159]  E. Cesarman.  The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[160]  M. Maloney,et al.  Therapeutic advances in melanoma. , 2000, Dermatologic clinics.

[161]  J. Timmerman,et al.  Dendritic cell vaccines for cancer immunotherapy. , 1999, Annual review of medicine.

[162]  E. Cesarman,et al.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. , 1995, Blood.

[163]  C. Cockerell.  Organ-specific manifestations of HIV infection. II. Update on cutaneous manifestations of HIV infection. , 1993, AIDS.

[164]  P. Leboit.  Dermatopathologic findings in patients infected with HIV. , 1992, Dermatologic clinics.

[165]  M. McGrath,et al.  AIDS associated non-Hodgkin's lymphomas represent a broad spectrum of monoclonal and polyclonal lymphoproliferative processes. , 1992, Current topics in microbiology and immunology.

[166]  Herndier Bg.  Surgical pathology of HIV associated lymphoproliferations. , 1991 .

[167]  C. Cockerell.  Histopathological features of Kaposi's sarcoma in HIV infected individuals. , 1991, Cancer surveys.

[168]  M. McGrath,et al.  AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. , 1991, Journal of acquired immune deficiency syndromes.

[169]  L. Medeiros,et al.  T-cell receptor gene rearrangements and the diagnosis of human T-cell neoplasms. , 1990, Critical reviews in oncology/hematology.

[170]  P. Volberding.  Kaposi's sarcoma in AIDS. , 1989, Immunology series.

[171]  C. Orfanos,et al.  Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma. , 1987, Dermatologica.

[172]  R. Dorfman.  Cutaneous and lymphadenopathic Kaposi's sarcoma in Africa and the USA with observations on persistent lymphadenopathy in homosexual men at risk for the acquired immunodeficiency syndrome. , 1985, Frontiers of radiation therapy and oncology.

[173]  A. Ackerman,et al.  Subtle clues to diagnosis by conventional microscopy. , 1980, The American Journal of dermatopathology.

[174]  K. Amazon,et al.  Subtle clues to diagnosis by conventional microscopy. Lymph node involvement in Kaposi's sarcoma. , 1979, The American Journal of dermatopathology.

[175]  Ackerman Ab.  Subtle clues to diagnosis by conventional microscopy. The patch stage of Kaposi's sarcoma. , 1979 .

[176]  Kadagidze Zg,et al.  Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy , 1977 .

[177]  S. Robbins,et al.  Pathologic basis of disease , 1974 .

[178]  W. Gill,et al.  Stewart-Treves syndrome. , 1968, Journal of the Royal College of Surgeons of Edinburgh.